{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:13:10Z","timestamp":1783710790750,"version":"3.55.0"},"reference-count":40,"publisher":"Xia & He Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,28]]},"DOI":"10.14218\/jcth.2017.00007","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T04:31:46Z","timestamp":1505363506000},"page":"1-5","source":"Crossref","is-referenced-by-count":6,"title":["Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents"],"prefix":"10.14218","volume":"5","author":[{"given":"George","family":"Cholankeril","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairin","family":"Joseph-Talreja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon J.","family":"Perumpail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2017,9,14]]},"reference":[{"key":"key20170914042200_b1","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/cncr.29936","article-title":"Annual Report to the Nation on the Status of Cancer, 1975\u20132012, featuring the increasing incidence of liver cancer","volume":"122","author":"Ryerson","year":"2016","journal-title":"Cancer"},{"key":"key20170914042200_b2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M13-1133","article-title":"Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010","volume":"160","author":"Denniston","year":"2014","journal-title":"Ann Intern Med"},{"key":"key20170914042200_b3","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/hep.27978","article-title":"Toward a more accurate estimate of the prevalence of hepatitis C in the United States","volume":"62","author":"Edlin","year":"2015","journal-title":"Hepatology"},{"key":"key20170914042200_b4","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1053\/j.gastro.2012.02.011","article-title":"Viral hepatitis in liver transplantation","volume":"142","author":"Crespo","year":"2012","journal-title":"Gastroenterology"},{"key":"key20170914042200_b5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.7326\/0003-4819-159-5-201309030-00672","article-title":"U.S. Preventive Services Task Force. Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement","volume":"159","author":"Moyer","year":"2013","journal-title":"Ann Intern Med"},{"key":"key20170914042200_b6","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis","volume":"308","author":"van der Meer","year":"2012","journal-title":"JAMA"},{"key":"key20170914042200_b7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/lt.24383","article-title":"Model for end-stage liver disease limbo, model for end-stage liver disease purgatory, and the dilemma of treating hepatitis C in patients awaiting liver transplantation","volume":"22","author":"Carrion","year":"2016","journal-title":"Liver Transpl"},{"key":"key20170914042200_b8","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/jvh.12534","article-title":"Treat chronic hepatitis C virus infection in decompensated cirrhosis - pre- or post-liver transplantation? the ironic conundrum in the era of effective and well-tolerated therapy","volume":"23","author":"Bunchorntavakul","year":"2016","journal-title":"J Viral Hepat"},{"key":"key20170914042200_b9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.gtc.2015.07.003","article-title":"Natural history of hepatitis C","volume":"44","author":"Lingala","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"key20170914042200_b10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/jama.2013.109309","article-title":"Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial","volume":"310","author":"Osinusi","year":"2013","journal-title":"JAMA"},{"key":"key20170914042200_b11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.gastro.2009.09.067","article-title":"Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression","volume":"138","author":"Davis","year":"2010","journal-title":"Gastroenterology"},{"key":"key20170914042200_b12","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1001\/jama.2015.2833","article-title":"Screening for hepatitis C","volume":"313","author":"Wray","year":"2015","journal-title":"JAMA"},{"key":"key20170914042200_b13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1365-2036.2007.03498.x","article-title":"Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis","volume":"26","author":"Snowberger","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"key20170914042200_b14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.14218\/JCTH.2013.00002","article-title":"Management of hepatitis C before and after liver transplantation in the era of rapidly evolving therapeutic advances","volume":"2","author":"Bunchorntavakul","year":"2014","journal-title":"J Clin Transl Hepatol"},{"key":"key20170914042200_b15","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3748\/wjg.v22.i4.1570","article-title":"Liver transplantation for viral hepatitis in 2015","volume":"22","author":"Ferrarese","year":"2016","journal-title":"World J Gastroenterol"},{"key":"key20170914042200_b16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12328-015-0602-y","article-title":"Spontaneous clearance of HCV accompanying hepatitis after liver transplantation","volume":"8","author":"Kogiso","year":"2015","journal-title":"Clin J Gastroenterol"},{"key":"key20170914042200_b17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199603283341302","article-title":"Long-term outcome of hepatitis C infection after liver transplantation","volume":"334","author":"Gane","year":"1996","journal-title":"N Engl J Med"},{"key":"key20170914042200_b18","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2002.32418","article-title":"The association between hepatitis C infection and survival after orthotopic liver transplantation","volume":"122","author":"Forman","year":"2002","journal-title":"Gastroenterology"},{"key":"key20170914042200_b19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease","volume":"149","author":"Charlton","year":"2015","journal-title":"Gastroenterology"},{"key":"key20170914042200_b20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2014.09.023","article-title":"Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study","volume":"148","author":"Curry","year":"2015","journal-title":"Gastroenterology"},{"key":"key20170914042200_b21","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/hep.25976","article-title":"A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation","volume":"57","author":"Everson","year":"2013","journal-title":"Hepatology"},{"key":"key20170914042200_b22","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/hep.28425","article-title":"Safety and efficacy of ledipasvir\/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older","volume":"63","author":"Saab","year":"2016","journal-title":"Hepatology"},{"key":"key20170914042200_b23","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection","volume":"373","author":"Feld","year":"2015","journal-title":"N Engl J Med"},{"key":"key20170914042200_b24","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1056\/NEJMoa1512612","article-title":"Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection","volume":"373","author":"Foster","year":"2015","journal-title":"N Engl J Med"},{"key":"key20170914042200_b25","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jhep.2016.01.029","article-title":"Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis","volume":"64","author":"Foster","year":"2016","journal-title":"J Hepatol"},{"key":"key20170914042200_b26","doi-asserted-by":"crossref","first-page":"S620","DOI":"10.1016\/S0168-8278(15)30977-6","article-title":"Ledipasvir\/sofosbuvir with ribavirin is safe in >600 decompensated and post liver transplantation patients with HCV infection: An integrated safety analysis of the solar 1 and solar 2 trials","volume":"62","author":"Samuel","year":"2015","journal-title":"J Hepatol"},{"key":"key20170914042200_b27","first-page":"66","article-title":"Timing of antiviral therapy in candidates for liver transplant for hepatitis C and hepatocellular carcinoma","volume":"14","author":"Saab","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"key20170914042200_b28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.dld.2016.12.027","article-title":"Common issues in the management of patients in the waiting list and after liver transplantation","volume":"49","author":"Burra","year":"2017","journal-title":"Dig Liver Dis"},{"key":"key20170914042200_b29","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1111\/ajt.13971","article-title":"Improving organ utilization to help overcome the tragedies of the opioid epidemic","volume":"16","author":"Goldberg","year":"2016","journal-title":"Am J Transplant"},{"key":"key20170914042200_b30","first-page":"7","article-title":"Implications of treating hepatitis C virus infection among patients awaiting cadaveric liver transplant: a single-center experience","volume":"13","author":"Ofosu","year":"2015","journal-title":"Exp Clin Transplant"},{"key":"key20170914042200_b31","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/TP.0000000000001611","article-title":"Before or after transplantation? a review of the cost effectiveness of treating waitlisted patients with hepatitis C","volume":"101","author":"Tapper","year":"2017","journal-title":"Transplantation"},{"key":"key20170914042200_b32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jhep.2006.10.017","article-title":"Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation","volume":"46","author":"Picciotto","year":"2007","journal-title":"J Hepatol"},{"key":"key20170914042200_b33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jhep.2008.05.002","article-title":"Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin","volume":"49","author":"Berenguer","year":"2008","journal-title":"J Hepatol"},{"key":"key20170914042200_b34","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/lt.24422","article-title":"Simeprevir and sofosbuvir with or without ribavirin to treat recurrent genotype 1 hepatitis C virus infection after orthotopic liver transplantation","volume":"22","author":"Crittenden","year":"2016","journal-title":"Liver Transpl"},{"key":"key20170914042200_b35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/ctr.12738","article-title":"Sofosbuvir and simeprevir without ribavirin effectively treat hepatitis C virus genotype 1 infection after liver transplantation in a two-center experience","volume":"30","author":"Jackson","year":"2016","journal-title":"Clin Transplant"},{"key":"key20170914042200_b36","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/TP.0000000000001126","article-title":"Sofosbuvir-based antiviral therapy is highly effective in recurrent hepatitis C in liver transplant recipients: canadian multicenter \u201creal-life\u201d experience","volume":"100","author":"Faisal","year":"2016","journal-title":"Transplantation"},{"key":"key20170914042200_b37","first-page":"38","article-title":"Sofosbuvir and simeprevir for the treatment of recurrent hepatitis C with fibrosing cholestatic hepatitis after liver transplantation","volume":"7","author":"Issa","year":"2016","journal-title":"Int J Organ Transplant Med"},{"key":"key20170914042200_b38","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jhep.2016.05.010","article-title":"Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study","volume":"65","author":"Belli","year":"2016","journal-title":"J Hepatol"},{"key":"key20170914042200_b39","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.29097","article-title":"Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry","volume":"65","author":"Fern\u00e1ndez Carrillo","year":"2017","journal-title":"Hepatology"},{"key":"key20170914042200_b40","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.29054","article-title":"The dynamic landscape of liver transplant in the era of effective hepatitis C virus therapy","volume":"65","author":"Verna","year":"2017","journal-title":"Hepatology"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.xiahepublishing.com\/ArticleFullText.aspx?sid=2&jid=1&id=10.14218%2fJCTH.2017.00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:16:54Z","timestamp":1783707414000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.xiahepublishing.com\/ArticleFullText.aspx?sid=2&jid=1&id=10.14218%2fJCTH.2017.00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,14]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,9,14]]},"published-print":{"date-parts":[[2017,12,28]]}},"alternative-id":["10.14218\/JCTH.2017.00007"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2017.00007","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,14]]}}}